NCT01190839

Who might be able to join this trial:

• You have been officially diagnosed with Crohn's disease, confirmed through camera examinations of the gut, tissue samples, and/or imaging scans before or during surgery
• You have had surgery to remove part of your small intestine and colon (ileocolonic resection)
• You are considered to be at a higher-than-average risk of your Crohn's disease coming back after surgery
• You have either never taken infliximab (a medication used to treat Crohn's disease) or have taken it before but did not have to stop due to side effects — previous use of similar medications (adalimumab or certolizumab) is allowed
• You have been tested for hepatitis B virus (HBV) before starting the trial
• Your Crohn's disease activity score (a measure of how active your symptoms are) is below 200, meaning your disease is currently not in an active flare
• Your blood and liver test results are within an acceptable range

Who may not be able to join:

• You have a history of certain serious fungal or bacterial infections, including histoplasmosis or coccidioidomycosis, before the screening period
• Your chest X-ray (taken within the last 3 months) shows any concerning findings, such as signs of cancer, infection, or tuberculosis (TB)
• You still had active Crohn's disease areas in your gut that were not removed during your surgery
• You do not meet the specific criteria for being at increased risk of Crohn's disease returning after surgery
• You currently have an active infection, or you have had a serious infection unrelated to Crohn's disease (such as hepatitis, pneumonia, or a kidney infection) within the past 6 months
• You have had a serious opportunistic infection (such as shingles, cytomegalovirus, or certain fungal or bacterial infections) within the past 6 months
• You have, or have had, any form of cancer within the past 5 years — with the exception of certain minor skin cancers that were fully removed and have not come back
• You have any other health condition that the trial doctor believes could put your wellbeing at risk or prevent you from fully participating in the trial

Important: Always verify eligibility with the trial site directly before applying.